Treating Periprosthetic Joint Infection With Silver-Impregnated Carbon-Coated Spacers: Mid-Term Outcomes

Abstract

Background. Periprosthetic joint infection (PJI) is a severe complication of arthroplasty. The widely accepted treatment standard for PJI is a two-stage revision arthroplasty involving the articulating spacers. The implant surface provides an ideal environment for bacterial adhesion, facilitating mature biofilm formation. To prevent bacterial adhesion effectively, the surface of the implanted device must be modified with an efficient coating. The ability of a modified coating based on two-dimensional linear carbon chains (2D LCC) with silver (Ag) impregnation to inhibit biofilm formation and provide efficient bacterial eradication has been investigated in several experimental studies. However, there is a lack of publications on clinical studies evaluating the effectiveness of such coatings.

The aim of the study — to assess mid-term outcomes of knee and hip PJI treatment using spacers coated with two-dimensional linear carbon chains impregnated with silver.

Methods. This study is based on the results of the examination and two-stage revision arthroplasty of 144 patients with newly diagnosed knee and hip PJI. Patients were divided into two groups: the first (main) group received articulating spacers coated with 2D LCC+Ag, while the second (control) group received articulating spacers with antibiotics. Anamnestic, clinical, laboratory, microbiological, and statistical methods were used in this study. The evaluation of short-term results was performed using the KSS, Harris, VAS, and EQ-5D-5L scales at 3 months after surgery, and mid-term results were assessed at 2 years.

Results. The study confirmed the high antibiofilm activity and safety of spacers coated with 2D LCC+Ag. Both groups showed a reduction in inflammation markers during treatment. Before the second stage of treatment, both groups experienced a statistically significant decrease in CRP, procalcitonin, and presepsin levels, as well as synovial cytosis and neutrophil content. The frequency of recurrences after two-stage treatment was significantly lower in the first group compared to the second group. In the mid-term period, the first group had higher scores on the KSS and Harris scales by 20.5 and 7.0 points, respectively. Results on the EQ-5D-5L were 10/0.08 points higher, and the intensity of pain according to VAS was three times lower in the first group.

Conclusion. The use of spacers coated with 2D LCC+Ag allows for a faster resolution of the inflammatory process, reduces the incidence of PJI recurrences, and predicts active protection of the implant surface from microbial colonization and biofilm formation. This, combined with antibiotic prophylaxis, provides a favorable therapeutic and preventive effect against PJI recurrence.

Keywords

arthroplasty / periprosthetic joint infection / implant-associated infection / microbial biofilms / antibacterial coating

References

[1] Bilgen S., Eken G. Surgical site infection after total knee arthroplasty: a descriptive study. Int Multispecialty J Heal. 2016;2(2). Available from: https://www.researchgate.net/publication/301520334_Surgical_Site_Infection_After_Total_Knee_Arthroplasty_A_Descriptive_Study.

[2] 1.Bilgen S., Eken G. Surgical site infection after total knee arthroplasty : a descriptive study. Int. Multispecialty J. Heal. 2016;2(№2):1–8.

[3] NiemeläInen M.J., MäKelä K.T., Robertsson O., W-Dahl A., Furnes O., Fenstad A.M. et al. Different incidences of knee arthroplasty in the Nordic countries. Acta Orthop. 2017;88(2):173-178. doi: 10.1080/17453674.2016.1275200.

[4] 2.NiemeläInen MJ, MäKelä KT, Robertsson O, W-Dahl A, Furnes O, Fenstad AM, Pedersen AB, Schrøder HM, Huhtala H, Eskelinen A. Different incidences of knee arthroplasty in the Nordic countries. Acta Orthop. 2017 Apr;88(2):173-178. https://doi.org/10.1080/17453674.2016.1275200. Epub 2017 Jan 6. PMID: 28056570; PMCID: PMC5385112.

[5] Tande A.J., Patel R. Prosthetic joint infection. Clin Microbiol Rev. 2014;27(2):302-345. doi: 10.1128/CMR.00111-13.

[6] 3.Koseki H, Yonekura A, Shida T, Yoda I, Horiuchi H, Morinaga Y, Yanagihara K, Sakoda H, Osaki M, Tomita M. Early staphylococcal biofilm formation on solid orthopaedic implant materials: in vitro study. PLoS One. 2014 Oct 9;9(10):e107588. https://doi.org/10.1371/journal.pone.0107588. PMID: 25299658; PMCID: PMC4191968.

[7] Fuchs M., von Roth P., Pfitzner T., Kopf S., Sass F.A., Hommel H. Contamination of irrigation fluid during primary total knee arthroplasty. J Am Acad Orthop Surg Glob Res Rev. 2018;2(5):e027. doi: 10.5435/JAAOSGlobal-D-17-00027.

[8] 4.Zimmerli W., Moser C. Pathogenesis and treatment concepts of orthopaedic biofilm infections. FEMS Immunol Med Microbiol. 2012;65(2):158-168. https://doi.org/10.1111/j.1574-695X.2012.00938.x.

[9] Grammatopoulos G., Kendrick B., McNally M., Athanasou N.A., Atkins B., McLardy-Smith P. et al. Outcome Following Debridement, Antibiotics, and Implant Retention in Hip Periprosthetic Joint Infection-An 18-Year Experience. J Arthroplasty. 2017;32(7):2248-2255. doi: 10.1016/j.arth.2017.02.066.

[10] 5.Tande AJ, Patel R. Prosthetic joint infection. Clin Microbiol Rev. 2014 Apr;27(2):302-45. https://doi.org/10.1128/CMR.00111-13. PMID: 24696437; PMCID: PMC3993098.

[11] Jhan S.W., Lu Y.D., Lee M.S., Lee C.H., Wang J.W., Kuo F.C. The risk factors of failed reimplantation arthroplasty for periprosthetic hip infection. BMC Musculoskelet Disord. 2017;18(1):255. doi: 10.1186/s12891-017-1622-1.

[12] 6.Fuchs M., von Roth P., Pfitzner T. et al. Contamination of irrigation fluid during primary total knee arthroplasty. Journal of the American Academy of Orthopaedic Surgeons. Global Research & Reviews. 2018;2(5):e027. https://doi.org/10.5435/JAAOSGlobal-D-17-00027.

[13] Akgün D., Müller M., Perka C., Winkler T. An often-unrecognized entity as cause of recurrent infection after successfully treated two-stage exchange arthroplasty: hematogenous infection. Arch Orthop Trauma Surg. 2018;138(9):1199-1206. doi: 10.1007/s00402-018-2972-3.

[14] 7.Grammatopoulos G, Kendrick B, McNally M, Athanasou NA, Atkins B, McLardy-Smith P, Taylor A, Gundle R. Outcome Following Debridement, Antibiotics, and Implant Retention in Hip Periprosthetic Joint Infection-An 18-Year Experience. J Arthroplasty. 2017 Jul;32(7):2248-2255. https://doi.org/10.1016/j.arth.2017.02.066. Epub 2017 Mar 6. PMID: 28385345.

[15] Koseki H., Yonekura A., Shida T., Yoda I., Horiuchi H., Morinaga Y. et al. Early staphylococcal biofilm formation on solid orthopaedic implant materials: in vitro study. PLoS One. 2014;9(10):e107588. doi: 10.1371/journal.pone.0107588.

[16] 8.Jhan S.W., Lu Y.D., Lee M.S. et al. The risk factors of failed reimplantation arthroplasty for periprosthetic hip infection. BMC Musculoskelet. Disord. 2017;18(1):1–7. https://doi.org/10.1186/s12891-017-1622-1

[17] Zimmerli W., Moser C. Pathogenesis and treatment concepts of orthopaedic biofilm infections. FEMS Immunol Med Microbiol. 2012;65(2):158-168. doi: 10.1111/j.1574-695X.2012.00938.x.

[18] 9.Akgün D, Müller M, Perka C, Winkler T. An often-unrecognized entity as cause of recurrent infection after successfully treated two-stage exchange arthroplasty: hematogenous infection. Arch Orthop Trauma Surg. 2018 Sep;138(9):1199-1206. https://doi.org/10.1007/s00402-018-2972-3. Epub 2018 Jun 5. PMID: 29868943.

[19] Шпиняк С.П., Барабаш А.П., Лясникова А.В. Применение спейсеров в лечении инфекционных осложнений тотального эндопротезирования коленного сустава. Современные проблемы науки и образования. 2015;5. Режим доступа: https://science-education.ru/ru/article/view?id=21443. (дата обращения: 22.03.2023). Shpinyak S.P., Barabash A.P., Lyasnikova A.V. The use of spacers in the treatment of infectious complications of total knee arthroplasty. Modern problems of science and education.2015;5. (In Russian). Available from: https://science-education.ru/ru/article/view?id=21443. (date of the application: 22.03.2023).

[20] 10.Шпиняк С.П., Барабаш А.П., Лясникова А.В. Применение спейсеров в лечении инфекционных осложнений тотального эндопротезирования коленного сустава. Современные проблемы науки и образования. 2015;5. URL: https://science-education.ru/ru/article/view?id=21443 (дата обращения: 22.03.2023).

[21] Комаров Р.Н., Новиков А.В., Митрофанов В.Н., Акулов М.М., Корыткин А.А. Применение спейсеров в лечении периимплантной инфекции после эндопротезирования тазобедренного сустава. Современные проблемы науки и образования. 2014;5. Режим доступа: https://science-education.ru/ru/article/view?id=14954. (дата обращения: 22.03.2023). Komarov R.N., Novikov A.V., Mitrofanov V.N., Akulov M.M., Korytkin A.A. The use of spacers during peri-implant infection after hip arthroplasty. Modern problems of science and education. 2014;5. (In Russian). Available from: https://science-education.ru/ru/article/view?id=14954. (date of the application: 22.03.2023).

[22] 11.Комаров Р.Н., Новиков А.В., Митрофанов В.Н., Акулов М.М., Корыткин А.А. Применение спейсеров в лечении периимплантной инфекции после эндопротезирования тазобедренного сустава. Современные проблемы науки и образования. 2014;5. URL: https://science-education.ru/ru/article/view?id=14954 (дата обращения: 22.03.2023).

[23] Leung D., Spratt D.A., Pratten J., Gulabivala K., Mordan N.J., Young A.M. Chlorhexidine-releasing methacrylate dental composite materials. Biomaterials. 2005;26(34):7145-7153. doi: 10.1016/j.biomaterials.2005.05.014.

[24] 12.Ермаков А.М., Клюшин Н.М., Абабков Ю.В. и др. Одноэтапное ревизионное эндопротезирование при лечении перипротезной инфекции тазобедренного сустава. Гений ортопедии. 2019;25(2):172–179. https://doi.org/10.18019/1028-4427-2019-25-2-172-179.

[25] Evans A., Kavanagh K.A. Evaluation of metal-based antimicrobial compounds for the treatment of bacterial pathogens. J Med Microbiol. 2021;70(5):001363. doi: 10.1099/jmm.0.001363.

[26] 13.Kose N, Otuzbir A, Pekşen C, Kiremitçi A, Doğan A. A silver ion-doped calcium phosphate-based ceramic nanopowder-coated prosthesis increased infection resistance. Clin Orthop Relat Res. 2013 Aug;471(8):2532-9. https://doi.org/10.1007/s11999-013-2894-x. PMID: 23463287; PMCID: PMC3705076.

[27] Ермаков А.М., Клюшин Н.М., Абабков Ю.В., Тряпичников А.С., Коюшков А.Н. Одноэтапное ревизионное эндопротезирование при лечении перипротезной инфекции тазобедренного сустава. Гений ортопедии. 2019;25(2):172-179. doi: 10.18019/1028-4427-2019-25-2-172-179. Ermakov A.M., Klyushin N.M., Ababkov Yu.V., Triapichnikov A.S., Koiushkov A.N. One-stage revision arthroplasty for management of periprosthetic hip infection. Genij Ortopedii. 2019;25(2):172-179. (In Russian). doi: 10.18019/1028-4427-2019-25-2-172-179.

[28] 14.Arciola C.R., Campoccia D., Speziale P. et al. Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials. Biomaterials. 2012;33: 5967–5982. https://doi.org/10.1016/j.biomaterials.2012.05.031

[29] Kose N., Otuzbir A., Pekşen C., Kiremitçi A., Doğan A. A silver ion-doped calcium phosphate-based ceramic nanopowder-coated prosthesis increased infection resistance. Clin Orthop Relat Res. 2013;471(8):2532-2539. doi: 10.1007/s11999-013-2894-x.

[30] 15.Bazaka K., Jacob M. V., Crawford R. J., Ivanova E. P. Efficient surface modification of biomaterial to prevent biofilm formation and the attachment of microorganisms. Appl. Microbiol. Biotechnol. 2012;95:299–311. https://doi.org/10.1007/s00253-012-4144-7.

[31] Arciola C.R., Campoccia D., Speziale P., Montanaro L., Costerton J.W. Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials. Biomaterials. 2012;33(26):5967-5982. doi: 10.1016/j.biomaterials.2012.05.031.

[32] 16.Grill A., Meyerson B.S. Development and status of diamond-like carbon. Synthetic Diamond: Emerging CVD Science and Technology / К. E. Spear [et al.]; ed. К. E. Spear. — New York, Wiley, 1994;91-141.

[33] Bazaka K., Jacob M.V., Crawford R.J., Ivanova E.P. Efficient surface modification of biomaterial to prevent biofilm formation and the attachment of microorganisms. Appl Microbiol Biotechnol. 2012;95: 299-311. doi: 10.1007/s00253-012-4144-7.

[34] 17.Казбанов В.В., Баталов М.С., Вишневский А.А. Особенности биосовместимости и перспективы применения титановых имплантатов с алмазоподобными покрытиями на основе модифицированного углерода. Проблемы здоровья и экологии. 2015;(2):16-23.

[35] Grill A., Meyerson B.S. Development and status of diamond-like carbon. In: Synthetic Diamond: Emerging CVD Science and Technology. Ed. by К.E. Spear, J.P. Dismukes. New York: Wiley; 1994. р. 91-141.

[36] 18.Бабаев В.Г., Новиков Н.Д., Гусева М.Б. и др. Пленки линейно-цепочечного углерода - упорядоченные ансамбли квантовых нитей - материал для наноэлектроники. Нанотехнологии: разработка, применение. 2010;2(№1):53-68.

[37] Казбанов В.В., Баталов М.С., Вишневский А.А. Особенности биосовместимости и перспективы применения титановых имплантатов с алмазоподобными покрытиями на основе модифицированного углерода. Проблемы здоровья и экологии. 2015;(2):16-23. doi: 10.51523/2708-6011.2015-12-2-4. Kazbanov V.V., Batalov M.S., Vishnevsky A.A. The peculiarities of biocompatibility and potential applications of titanium implants with diamond-like coatings based on modified carbon. Health Ecology Issues. 2015;(2):16-23. (In Russian). doi: 10.51523/2708-6011.2015-12-2-4.

[38] 19.Тапальский Д.В., Николаев Н.С., Овсянкин А.В., Кочаков В.Д., Головина Е.А., Матвеенков М.В., Сухорукова М.В., Козлов Р.С. Покрытия на основе двумерно упорядоченного линейно-цепочечного углерода для защиты титановых имплантатов от микробной колонизации. Травматология и ортопедия России. 2019;25(2):111-120. https://doi.org/10.21823/2311-2905-2019-25-2-111-120

[39] Бабаев В.Г., Новиков Н.Д., Гусева М.Б., Хвостов В.В., Савченко Н.Ф., Коробова Ю.Г. и др. Пленки линейно-цепочечного углерода — упорядоченные ансамбли квантовых нитей — материал для наноэлектроники. Нанотехнологии: разработка, применение — XXI век. 2010;2(1):53-68. Babaev V.G., Novikov N.D., Guseva M.B., Khvostov V.V., Savchenko N.F., Korobova Yu.G. et al. Films of linear-chain carbon — ordered ensembles of quantum wires — material for nanoelectronics. Nanotechnology: development and applications — XXI century. 2010;2(41):53-68. (In Russian).

[40] 20.Кириченко М.С., Панин С.В. Разработка адаптивного алгоритма оценки информативности динамических признаков для обработки и анализа изображений. Вычислительные технологии. 2005;1(10):58–70.

[41] Тапальский Д.В., Николаев Н.С., Овсянкин А.В., Кочаков В.Д., Головина Е.А., Матвеенков М.В. и др. Покрытия на основе двумерно упорядоченного линейно-цепочечного углерода для защиты титановых имплантатов от микробной колонизации. Травматология и ортопедия России. 2019;25(2):111-120. doi: 10.21823/2311-2905-2019-25-2-111-120. Tapal’skii D.V., Nikolaev N.S., Ovsyankin A.V., Kochakov V.D., Golovina E.A., Matveenkov M.V. et al. Coatings based on two-dimensionally ordered linear chain carbon for protection of titanium implants from microbial colonization. Traumatology and Orthopedics in Russia. 2019;25(2):111-120. (In Russian). doi: 10.21823/2311-2905-2019-25-2-111-120.

[42] 21.Петри А., Сабина К. Наглядная медицинская статистика: учеб. пособие / пер. с англ. под ред. В.П. Леонова. – 3-е изд., перераб., и доп. М.: ГЭОТАР-Медиа. 2015. 216 с.

[43] Parvizi J., Gehrke T., Chen A.F. Proceedings of the International Consensus on Periprosthetic Joint Infection. Bone Joint J. 2013;95-B(11):1450-1452. doi: 10.1302/0301-620X.95B11.33135.

[44] 22.Fiore, M., Sambri, A., Zucchini, R. et al. Silver-coated megaprosthesis in prevention and treatment of peri-prosthetic infections: a systematic review and meta-analysis about efficacy and toxicity in primary and revision surgery. Eur J Orthop Surg Traumatol. 2021;31:201–220. https://doi.org/10.1007/s00590-020-02779-z

[45] Fiore M., Sambri A., Zucchini R. et al. Silver-coated megaprosthesis in prevention and treatment of periprosthetic infections: a systematic review and meta-analysis about efficacy and toxicity in primary and revision surgery. Eur J Orthop Surg Traumatol. 2021;31:201-220. doi: 10.1007/s00590-020-02779-z.

[46] 23.Павлов В.В., Петрова Н.В., Шералиев Т.У. Среднесрочные результаты двухэтапного лечения перипротезной инфекции. Травматология и ортопедия России. 2019;25(4):109-116. https://doi.org/10.21823/2311-2905-2019-25-4-109-116. Pavlov V.V., Petrova N.V., Sheraliev T.u. [Two-Stage Treatment of Periprostetic Infection: Mid-Term Results]. Travmatologiya i ortopediya Rossii [Traumatology and orthopedics of Russia]. 2019;25(4):109-116. (In Russian). https://doi.org/10.21823/2311-2905-2019-25-4-109-116

[47] Павлов В.В., Петрова Н.В., Шералиев Т.У. Среднесрочные результаты двухэтапного лечения перипротезной инфекции. Травматология и ортопедия России. 2019;25(4):109-116. doi: 10.21823/2311-2905-2019-25-4-109-116. Pavlov V.V., Petrova N.V., Sheraliev T.U. Two-stage treatment of periprostetic infection: mid-term results. Traumatology and Orthopedics of Russia. 2019;25(4):109-116. (In Russian). doi: 10.21823/2311-2905-2019-25-4-109-116.

[48] 24.Иванцов В.А., Лашковский В.В., Богданович И.П., Лазаревич С.Н. Лечение глубокой перипротезной инфекции коленного сустава. Журнал ГрГМУ. 2018; №1. URL: https://cyberleninka.ru/article/n/lechenie-glubokoy-periproteznoy-infektsii-kolennogo-sustava (дата обращения: 20.03.2023)

[49] Иванцов В.А., Лашковский В.В., Богданович И.П., Лазаревич С.Н. Лечение глубокой перипротезной инфекции коленного сустава. Журнал Гродненского государственного медицинского университета. 2018; 16(1):96-100. doi: 10.25298/2221-8785-2018-16-1-96-100. Ivantsov V.A., Lashkovsky V.V, Bogdanovich I.P, Lazarevich S.N. Treatment of deep periprosthetic infection of knee joint. Journal of the Grodno State Medical University. 2018;16(1):96-100. doi: 10.25298/2221-8785-2018-16-1-96-100.

[50] 25.Schwolow F, Füchtmeier B, Müller F. Factors associated with infection recurrence after two-stage exchange for periprosthetic hip infection. Int Orthop. 2022 May;46(5):953-961. doi: 10.1007/s00264-022-05333-0. Epub 2022 Feb 7. PMID: 35129644.

[51] Schwolow F., Füchtmeier B., Müller F. Factors associated with infection recurrence after two-stage exchange for periprosthetic hip infection. Int Orthop. 2022;46(5): 953-961. doi: 10.1007/s00264-022-05333-0.

[52] 26.Steinicke AC, Schwarze J, Gosheger G, Moellenbeck B, Ackmann T, Theil C. Repeat two-stage exchange arthroplasty for recurrent periprosthetic hip or knee infection: what are the chances for success? Arch Orthop Trauma Surg. 2022 Jan 4. https://doi.org/10.1007/s00402-021-04330-z. Epub ahead of print. PMID: 34982202.

[53] Steinicke A.C., Schwarze J., Gosheger G., Moellenbeck B., Ackmann T., Theil C. Repeat two-stage exchange arthroplasty for recurrent periprosthetic hip or knee infection: what are the chances for success? Arch Orthop Trauma Surg. 2023;143(4):1731-1740. doi: 10.1007/s00402-021-04330-z.

[54] 27.Shirai T, Tsuchiya H, Terauchi R, Tsuchida S, Mizoshiri N, Mori Y, Takeuchi A, Hayashi K, Yamamoto N, Ikoma K, Kubo T. A retrospective study of antibacterial iodine-coated implants for postoperative infection. Medicine (Baltimore). 2019 Nov;98(45):e17932. https://doi.org/10.1097/MD.0000000000017932. PMID: 31702678; PMCID: PMC6855576.

[55] Shirai T., Tsuchiya H., Terauchi R., Tsuchida S., Mizoshiri N., Mori Y. et al. A retrospective study of antibacterial iodine-coated implants for postoperative infection. Medicine (Baltimore). 2019;98(45):e17932. doi: 10.1097/MD.0000000000017932.

[56] 28.Preobrazhensky PM, Bozhkova SA, Kazemirsky AV, Tikhilov RM, Kulaba TA, Kornilov NN. Functional outcome of two-stage reimplantation in patients with periprosthetic joint infection after primary total knee arthroplasty. Int Orthop. 2019 Nov;43(11):2503-2509. https://doi.org/10.1007/s00264-019-04296-z. Epub 2019 Jan 16. PMID: 30652221.

[57] Kim D.Y., Seo Y.C., Kim C.W., Lee C.R., Jung S.H. Factors affecting range of motion following two-stage revision arthroplasty for chronic periprosthetic knee infection. Knee Surg Relat Res. 2022;34(1):33. doi: 10.1186/s43019-022-00162-2.

[58] 29.Cahill JL, Shadbolt B, Scarvell JM, Smith PN. Quality of life after infection in total joint replacement. J Orthop Surg (Hong Kong). 2008 Apr;16(1):58-65. https://doi.org/10.1177/230949900801600115. PMID: 18453662.

[59] Golgelioglu F., Oguzkaya S., Misir A., Guney A. The effect of time spent with a dynamic spacer on clinical and functional outcomes in two-stage revision knee arthroplasty. Indian J Orthop. 2020;54(6):824-830. doi: 10.1007/s43465-020-00247-8.

[60] 30.Poulsen NR, Mechlenburg I, Søballe K, Lange J. Patient-reported quality of life and hip function after 2-stage revision of chronic periprosthetic hip joint infection: a cross-sectional study. Hip Int. 2018 Jul;28(4):407-414. https://doi.org/10.5301/hipint.5000584. Epub 2017 Apr 12. PMID: 29218685.

[61] Cahill J.L., Shadbolt B., Scarvell J.M., Smith P.N. Quality of life after infection in total joint replacement. J Orthop Surg (Hong Kong). 2008;16(1):58-65. doi: 10.1177/230949900801600115.

[62] Poulsen N.R., Mechlenburg I., Søballe K., Lange J. Patient-reported quality of life and hip function after 2-stage revision of chronic periprosthetic hip joint infection: a cross-sectional study. Hip Int. 2018;28(4):407-414. doi: 10.5301/hipint.5000584.

RIGHTS & PERMISSIONS

Eco-Vector